Development of nuclear factor kappa B inhibitors: synthesis and evaluation of lantadene congeners as anticancer agents

被引：0
|
作者：
Sharma, M. [1 ]
机构：
[1] Jaypee Univ Informat Technol, Pharm, Waknaghat, India
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
Lantadene; nuclear factor kappa B;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
SUN-141
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] Novel lung adenocarcinoma and nuclear factor-kappa B (NF-κB) inhibitors: Synthesis and evaluation of lantadene congeners
    Suthar, Sharad Kumar
    Boon, Hong L.
    Sharma, Manu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 74 : 135 - 144
  • [2] Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation
    Monika
    Sharma, Ankesh
    Suthar, Sharad Kumar
    Aggarwal, Vaibhav
    Lee, Hong Boon
    Sharma, Manu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 3814 - 3818
  • [3] Inhibitors of nuclear factor kappa B cause apoptosis in cultured macrophages
    Mannick, EE
    Mishra, J
    Marque, J
    Clavell, M
    Miller, MJS
    Oliver, PD
    MEDIATORS OF INFLAMMATION, 1997, 6 (03) : 225 - 232
  • [4] Cell penetrating peptide inhibitors of Nuclear Factor-kappa B
    Orange, J. S.
    May, M. J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (22) : 3564 - 3591
  • [5] Cell penetrating peptide inhibitors of Nuclear Factor-kappa B
    J. S. Orange
    M. J. May
    Cellular and Molecular Life Sciences, 2008, 65 : 3564 - 3591
  • [6] Novel Dual Inhibitors of Nuclear Factor-Kappa B (NF-κB) and Cyclooxygenase-2 (COX-2): Synthesis, In Vitro Anticancer Activity and Stability Studies of Lantadene-Non Steroidal Anti-inflammatory Drug (NSAID) Conjugates
    Suthar, Sharad Kumar
    Sharma, Neetika
    Lee, Hong Boon
    Nongalleima, Khumukcham
    Sharma, Manu
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (08) : 991 - 1004
  • [7] Potentiation of Chemotherapeutic Agents following Antagonism of Nuclear Factor kappa B in Human Gliomas
    Kyle D. Weaver
    Susan Yeyeodu
    James C. Cusack
    Albert S. Baldwin
    Matthew G. Ewend
    Journal of Neuro-Oncology, 2003, 61 : 187 - 196
  • [8] Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas
    Weaver, KD
    Yeyeodu, S
    Cusack, JC
    Baldwin, AS
    Ewend, MG
    JOURNAL OF NEURO-ONCOLOGY, 2003, 61 (03) : 187 - 196
  • [9] Inhibition of Nuclear Factor Kappa B Prevents the Development of Experimental Periapical Lesions
    Kaneko, Tomoatsu
    Zaw, Su Yee Myo
    Sueyama, Yukiko
    Katsube, Ken-ichi
    Kaneko, Reika
    Nor, Jacques E.
    Okiji, Takashi
    JOURNAL OF ENDODONTICS, 2019, 45 (02) : 168 - 173
  • [10] Involvement of nuclear factor-kappa B activation in IgE synthesis in human B cells
    Yanagihara, Y
    Basaki, Y
    Ikizawa, K
    Kajiwara, K
    Koshio, T
    Akiyama, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) : S224 - S229
12345